Detalhe da pesquisa
1.
SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.
Breast Cancer Res Treat
; 158(3): 485-95, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27393622
2.
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
Ann Oncol
; 26(2): 259-71, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25214542
3.
Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).
Osteoporos Int
; 26(7): 1971-7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25749740
4.
EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial.
Br J Cancer
; 111(6): 1065-71, 2014 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25117817
5.
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.
Br J Cancer
; 111(6): 1241-8, 2014 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25117820
6.
N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial.
Ann Oncol
; 24(10): 2548-2554, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23798616
7.
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
Ann Oncol
; 29(10): 2150, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29390054
8.
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.
Ann Oncol
; 24(2): 355-361, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23028039
9.
Validation of the use of Actigraph GT3X accelerometers to estimate energy expenditure in full time manual wheelchair users with spinal cord injury.
Spinal Cord
; 51(12): 898-903, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23999111
10.
A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group.
Ann Oncol
; 23(2): 331-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21821545
11.
Kaplan-Meier Type Survival Curves for COVID-19: A Health Data Based Decision-Making Tool.
Front Public Health
; 9: 646863, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34760856
12.
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
Ann Oncol
; 21(3): 493-497, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19625343
13.
North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer.
Ann Oncol
; 21(2): 269-274, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19901014
14.
Immunoscoring breast cancer: TILs remember what they target.
Ann Oncol
; 25(8): 1455-6, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24950980
15.
Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.
Ann Oncol
; 19(9): 1561-5, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18534964
16.
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Ann Oncol
; 19(7): 1231-1241, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18325918
17.
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
Ann Oncol
; 19(5): 877-82, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18332043
18.
Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.
Ann Oncol
; 18 Suppl 8: viii26-35, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17890211
19.
Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen.
J Natl Cancer Inst
; 81(10): 790-4, 1989 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-2541260
20.
Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis.
J Clin Oncol
; 13(4): 1036-43, 1995 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-7707101